Venus Remedies Limited Asset Resilience Ratio

Latest as of September 2025: 30.75%

Venus Remedies Limited asset resilience ratio. Venus Remedies Limited (VENUSREM) has an Asset Resilience Ratio of 30.75% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Venus Remedies Limited (VENUSREM) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs2.36 Billion

≈ $25.54 Million USD Cash + Short-term Investments

Total Assets

Rs7.68 Billion

≈ $83.07 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Venus Remedies Limited (2006–2025)

Asset resilience ratio of Venus Remedies Limited from 2006 to 2025. This chart shows how Venus Remedies Limited's Asset Resilience Ratio has changed over time. Read Venus Remedies Limited debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Venus Remedies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see VENUSREM asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs219.90 Million	2.86%
Short-term Investments	Rs2.14 Billion	27.89%
Total Liquid Assets	Rs2.36 Billion	30.75%

Asset Resilience Insights

Very High Liquidity: Venus Remedies Limited maintains exceptional liquid asset reserves at 30.75% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Venus Remedies Limited Industry Peers by Asset Resilience Ratio

Compare Venus Remedies Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Venus Remedies Limited Asset Resilience Ratio by Year (2006–2025)

Venus Remedies Limited asset resilience ratio by year from 2006 to 2025. The table below shows the annual Asset Resilience Ratio data for Venus Remedies Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	21.84%	Rs1.56 Billion ≈ $16.90 Million	Rs7.16 Billion ≈ $77.40 Million	+8.47pp
2024-03-31	13.37%	Rs838.05 Million ≈ $9.06 Million	Rs6.27 Billion ≈ $67.79 Million	+1.38pp
2023-03-31	11.99%	Rs720.75 Million ≈ $7.79 Million	Rs6.01 Billion ≈ $65.00 Million	+4.18pp
2022-03-31	7.81%	Rs453.11 Million ≈ $4.90 Million	Rs5.80 Billion ≈ $62.71 Million	+2.55pp
2021-03-31	5.26%	Rs292.55 Million ≈ $3.16 Million	Rs5.56 Billion ≈ $60.11 Million	+4.94pp
2020-03-31	0.32%	Rs20.42 Million ≈ $220.88K	Rs6.38 Billion ≈ $68.97 Million	+0.01pp
2019-03-31	0.31%	Rs23.01 Million ≈ $248.80K	Rs7.33 Billion ≈ $79.25 Million	-0.65pp
2018-03-31	0.96%	Rs72.21 Million ≈ $780.93K	Rs7.51 Billion ≈ $81.20 Million	-7.66pp
2017-03-31	8.63%	Rs715.21 Million ≈ $7.73 Million	Rs8.29 Billion ≈ $89.67 Million	+8.30pp
2006-03-31	0.33%	Rs2.04 Million ≈ $22.07K	Rs622.28 Million ≈ $6.73 Million	--

pp = percentage points

About Venus Remedies Limited

NSE:VENUSREM India Drug Manufacturers - Specialty & Generic

Market Cap

$190.12 Million

Rs17.58 Billion INR

Market Cap Rank

#16521 Global

#848 in India

Share Price

Rs1315.20

Change (1 day)

+1.13%

52-Week Range

Rs441.75 - Rs1947.00

All Time High

Rs1947.00